CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Salt Lake City, Utah, United States and 209 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
Salt Lake City, Utah, United States and 210 other locations
and safety of osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive non...
Phase 3
Salt Lake City, Utah, United States and 118 other locations
and in combination with pembrolizumab in patients with advanced non-small cell lung cancer and colorecta...
Phase 1
Salt Lake City, Utah, United States and 14 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Ogden, Utah, United States and 285 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Salt Lake City, Utah, United States and 262 other locations
with osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC)....
Phase 1, Phase 2
Salt Lake City, Utah, United States and 30 other locations
in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...
Phase 3
Salt Lake City, Utah, United States and 206 other locations
and preliminary antitumor activity of STX-721 in participants with non-small cell lung cancer (NSCLC) ca...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 14 other locations
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...
Phase 3
Ogden, Utah, United States of America and 128 other locations
Clinical trials
Research sites
Resources
Legal